Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
New Drug Research and Development	803.00K	25.70M
New Drug Research and Development Growth	-96.88%	-
Total	803.00K	25.70M
Total Growth	-96.88%	-

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Switzerland	-	624.00K
United State of America	803.00K	25.07M
United State of America Growth	-96.80%	-
Total	803.00K	25.70M
Total Growth	-96.88%	-

Source: S&P Global Market Intelligence.